Krasselt, M.; Gruz, N.; Pierer, M.; Baerwald, C.; Wagner, U.
IL-10 Induced by mTNF Crosslinking-Mediated Reverse Signaling in a Whole Blood Assay Is Predictive of Response to TNFi Therapy in Rheumatoid Arthritis. J. Pers. Med. 2022, 12, 1003.
https://doi.org/10.3390/jpm12061003
AMA Style
Krasselt M, Gruz N, Pierer M, Baerwald C, Wagner U.
IL-10 Induced by mTNF Crosslinking-Mediated Reverse Signaling in a Whole Blood Assay Is Predictive of Response to TNFi Therapy in Rheumatoid Arthritis. Journal of Personalized Medicine. 2022; 12(6):1003.
https://doi.org/10.3390/jpm12061003
Chicago/Turabian Style
Krasselt, Marco, Natalya Gruz, Matthias Pierer, Christoph Baerwald, and Ulf Wagner.
2022. "IL-10 Induced by mTNF Crosslinking-Mediated Reverse Signaling in a Whole Blood Assay Is Predictive of Response to TNFi Therapy in Rheumatoid Arthritis" Journal of Personalized Medicine 12, no. 6: 1003.
https://doi.org/10.3390/jpm12061003
APA Style
Krasselt, M., Gruz, N., Pierer, M., Baerwald, C., & Wagner, U.
(2022). IL-10 Induced by mTNF Crosslinking-Mediated Reverse Signaling in a Whole Blood Assay Is Predictive of Response to TNFi Therapy in Rheumatoid Arthritis. Journal of Personalized Medicine, 12(6), 1003.
https://doi.org/10.3390/jpm12061003